April 29, 2025

Can Five Proteins Predict Liver Disease?

"Imagine if we could predict risk of metabolic dysfunction-associated steatotic liver disease (MASLD) years before it starts."

Conexiant

April 29, 2025

New Oral Option Approved for GCA

The FDA approved Rinvoq (upadacitinib) as the first and only oral Janus kinase inhibitor for the treatment of giant cell arteritis in adults, providing a steroid-sparing option for achieving sustained remission.

Conexiant

April 29, 2025

Surgical Management of Foreign Body Ingestion in Adults: Case Series

Diagnosis relies heavily on a careful history, including the nature of the ingested material, and complementary imaging studies.

Conexiant

April 29, 2025

Female Surgeons Linked to Better Long-Term Outcomes

"These effects of both physician sex and patient-physician sex concordance are pervasive across medicine."

Conexiant

April 29, 2025

New Drug Tames Resistant High Blood Pressure

Lorundrostat reduces blood pressure significantly in patients with treatment-resistant hypertension by targeting aldosterone production.

Conexiant

April 28, 2025

Can Lower Blood Pressure Prevent Dementia?

‘Intensive BP reduction is effective in lowering the risk of all-cause dementia,’ a large trial finds

Conexiant

April 28, 2025

Brisk Walking Linked to Reduced Arrhythmia Risk Study

Faster walking pace was associated with a decreased risk of cardiac arrhythmias, researchers wrote in the UK Biobank study.

Conexiant

April 28, 2025

Oral Semaglutide Cuts Cardiovascular Event Risk

Oral semaglutide was superior to placebo in reducing the risk of major adverse cardiovascular events, researchers reported in the SOUL trial involving over 9,600 adults with high-risk type 2 diabetes.

Conexiant

April 28, 2025

Hormone Therapy Shows Mixed Effects on Heart Biomarkers

In WHI trial, hormone therapy reduced LDL and insulin resistance but raised triglycerides, with strongest lipoprotein(a) reductions seen in Native and Asian women.

Conexiant